- Panitumumab in the first-line treatment of elderly patients - results of the PANDA study2021 | Publication without faculty affiliation
- Osimertinib and its role in first-line NSCLC treatment2020 | Publication without faculty affiliation
- Alektinib v první linii léčby u nemocné s adenokarcinomem plic2020 | Third Faculty of Medicine
- Immunotherapy in the first line treatment of non-small cell lung cancer2021 | Publication without faculty affiliation
- Denosumab in the first line treatment of osteoporosis2020 | Third Faculty of Medicine
- Imunoterapie v první linii léčby nemalobuněčného karcinomu plic2017 | Publication without faculty affiliation
- Pembrolizumab v první linii léčby nemalobuněčného karcinomu plic - kazuistiky2018 | First Faculty of Medicine
- Alectinib v první linii léčby metastatického NSCLC s pozitivní přestavbou genu ALK2019 | Second Faculty of Medicine
- Atezolizumab in the first line of treatment for non-squamous metastatic non-small cell lung cancer2019 | Second Faculty of Medicine
- Imatinib in the first-line treatment of chronic myelogenous leukemia in chronic phase2008 | First Faculty of Medicine
- Imatinib in the first-line treatment of chronic myelogenous leukemia in chronic phase2008 | Publication without faculty affiliation
- Advanced stages of classical Hodgkin lymphoma - first-line treatment options2021 | Third Faculty of Medicine
- Cetuximab in the first line treatment of colorectal cancer2008 | First Faculty of Medicine
- Panitumumab as first-line treatment of colorectal cancer2019 | Publication without faculty affiliation
- Cetuximab v první linii léčby metastatického kolorektálního karcinomu2016 | First Faculty of Medicine
- Pembrolizumab v první linii léčby nemalobuněčného karcinomu plic2018 | Second Faculty of Medicine
- Immunotherapy in the first line treatment of non-small cell lung cancer2020 | Faculty of Medicine in Pilsen
- Lasting effect of pazopanib in first-line treatment of renal cell carcinoma2015 | First Faculty of Medicine
- Imunoterapie v první linii léčby metastatického nemalobuněčného plicního karcinomu2019 | Second Faculty of Medicine
- Imunoterapie v první linii léčby metastazujícího nemalobuněčného plicního karcinomu2019 | Second Faculty of Medicine
- First-line pembrolizumab for metastatic non-small-cell lung cancer2020 | First Faculty of Medicine
- First-line treatment for non-squamous NSCLC without driver mutations2022 | Third Faculty of Medicine
- Stabilizace onemocnění při kombinaci FOLFIRI s přípravkem Zaltrap, podané ve druhé linii u pacientky s krátkou dobou odpovědi na první linii léčby2020 | Third Faculty of Medicine
- Statins in the first-line therapy of acute coronary syndrome – similar to aspirin?2005 | Central Library of Charles University
- Pertuzumab as first-line treatment of patients with metastatic HER2-positive breast cancer2012 | Publication without faculty affiliation
- First-line immunotherapy in NSCLC - what brought 20182018 | Faculty of Medicine in Pilsen
- Mají inhibitory TNF stále místo v první linii léčby revmatoidní artritidy?2021 | First Faculty of Medicine
- Chemotherapy with a combination of irinotekan and cis- or carboplatin in first-line treatment of small-cell lung cancer2006 | Faculty of Medicine in Pilsen
- Chemotherapy with a combination of irinotekan and cis- or carboplatin in first-line treatment of small-cell lung cancer2006 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Advanced hepatocellular carcinoma and successfully targeted the first-line treatment with atezolizumab and bevacizumab according to IMbrave150 trial2021 | Faculty of Medicine in Pilsen